$52.45
-0.31-0.59%
Last update: Jan 23, 10:01 AM
Comments
Loading...
Dianthus Therapeutics Stock Guidance | NASDAQ:DNTH | Benzinga
Dianthus Therapeutics issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
FAQ
What is the most recent guidance for Dianthus Therapeutics (DNTH)?
There have been no specific sales or earnings guidance reported for Dianthus Therapeutics in recent months.
Browse guidance and forecast on all stocks.
